CN106236758A - 一种治疗鸡呼吸道细菌和病毒混合型感染的复方制剂及其制备方法 - Google Patents
一种治疗鸡呼吸道细菌和病毒混合型感染的复方制剂及其制备方法 Download PDFInfo
- Publication number
- CN106236758A CN106236758A CN201610624322.2A CN201610624322A CN106236758A CN 106236758 A CN106236758 A CN 106236758A CN 201610624322 A CN201610624322 A CN 201610624322A CN 106236758 A CN106236758 A CN 106236758A
- Authority
- CN
- China
- Prior art keywords
- preparation
- cosolvent
- compound preparation
- correctives
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 61
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 36
- 150000001875 compounds Chemical class 0.000 title claims abstract description 35
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 29
- 241000700605 Viruses Species 0.000 title claims abstract description 25
- 230000000241 respiratory effect Effects 0.000 title claims abstract description 21
- 208000015181 infectious disease Diseases 0.000 title abstract description 13
- PTNZGHXUZDHMIQ-UHFFFAOYSA-N 4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2C(C)C(C(O)C3C(C(O)=C(C(N)=O)C(=O)C3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960004082 doxycycline hydrochloride Drugs 0.000 claims abstract description 27
- OMZHXQXQJGCSKN-UHFFFAOYSA-N ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)-1h-indol-1-ium-3-carboxylate;chloride Chemical compound Cl.CN1C2=CC(Br)=C(O)C(CN(C)C)=C2C(C(=O)OCC)=C1CSC1=CC=CC=C1 OMZHXQXQJGCSKN-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000006184 cosolvent Substances 0.000 claims abstract description 20
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 16
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 16
- 229930195725 Mannitol Natural products 0.000 claims description 16
- 239000000594 mannitol Substances 0.000 claims description 16
- 235000010355 mannitol Nutrition 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 235000010413 sodium alginate Nutrition 0.000 claims description 16
- 239000000661 sodium alginate Substances 0.000 claims description 16
- 229940005550 sodium alginate Drugs 0.000 claims description 16
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 15
- 229960001031 glucose Drugs 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 238000010348 incorporation Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims 2
- KCFYEAOKVJSACF-UHFFFAOYSA-N umifenovir Chemical compound CN1C2=CC(Br)=C(O)C(CN(C)C)=C2C(C(=O)OCC)=C1CSC1=CC=CC=C1 KCFYEAOKVJSACF-UHFFFAOYSA-N 0.000 claims 2
- 229960004626 umifenovir Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 11
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 210000002345 respiratory system Anatomy 0.000 abstract description 5
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 235000019629 palatability Nutrition 0.000 abstract description 4
- 238000005553 drilling Methods 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000003449 preventive effect Effects 0.000 abstract description 3
- 235000013330 chicken meat Nutrition 0.000 description 32
- 239000000843 powder Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 229960001855 mannitol Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000018569 Respiratory Tract disease Diseases 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 229960003722 doxycycline Drugs 0.000 description 2
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005065 mining Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (6)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610624322.2A CN106236758B (zh) | 2016-07-29 | 2016-07-29 | 一种治疗鸡呼吸道细菌和病毒混合型感染的复方制剂及其制备方法 |
CN202010607132.6A CN111870597A (zh) | 2016-07-29 | 2016-07-29 | 一种易于实现产业化的治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
CN202010607658.4A CN112315957A (zh) | 2016-07-29 | 2016-07-29 | 一种预防和治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610624322.2A CN106236758B (zh) | 2016-07-29 | 2016-07-29 | 一种治疗鸡呼吸道细菌和病毒混合型感染的复方制剂及其制备方法 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010607132.6A Division CN111870597A (zh) | 2016-07-29 | 2016-07-29 | 一种易于实现产业化的治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
CN202010607658.4A Division CN112315957A (zh) | 2016-07-29 | 2016-07-29 | 一种预防和治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106236758A true CN106236758A (zh) | 2016-12-21 |
CN106236758B CN106236758B (zh) | 2020-07-28 |
Family
ID=57607148
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010607132.6A Pending CN111870597A (zh) | 2016-07-29 | 2016-07-29 | 一种易于实现产业化的治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
CN201610624322.2A Active CN106236758B (zh) | 2016-07-29 | 2016-07-29 | 一种治疗鸡呼吸道细菌和病毒混合型感染的复方制剂及其制备方法 |
CN202010607658.4A Withdrawn CN112315957A (zh) | 2016-07-29 | 2016-07-29 | 一种预防和治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010607132.6A Pending CN111870597A (zh) | 2016-07-29 | 2016-07-29 | 一种易于实现产业化的治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010607658.4A Withdrawn CN112315957A (zh) | 2016-07-29 | 2016-07-29 | 一种预防和治疗鸡呼吸道混合型感染的复方制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN111870597A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011100528A2 (en) * | 2010-02-12 | 2011-08-18 | Emory University | Compositions and uses of lectins |
CN102813909A (zh) * | 2012-08-02 | 2012-12-12 | 青岛绿曼生物工程有限公司 | 防治家禽大肠杆菌病和慢性呼吸道疾病的复方盐酸多西环素组合物及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742720A (zh) * | 2005-09-20 | 2006-03-08 | 江苏吴中苏药医药开发有限责任公司 | 一种阿比多尔制剂及其制备方法 |
CN102000030B (zh) * | 2010-11-08 | 2012-11-21 | 东北制药(沈阳)科技发展有限公司 | 一种阿比朵尔干混悬剂及其制备方法 |
CN110522733A (zh) * | 2015-11-06 | 2019-12-03 | 石家庄四药有限公司 | 一种阿比多尔及其盐干混悬剂及其制备方法 |
CN105614161A (zh) * | 2015-12-27 | 2016-06-01 | 陈洪福 | 一种鱼虾用饲料及其制备方法 |
-
2016
- 2016-07-29 CN CN202010607132.6A patent/CN111870597A/zh active Pending
- 2016-07-29 CN CN201610624322.2A patent/CN106236758B/zh active Active
- 2016-07-29 CN CN202010607658.4A patent/CN112315957A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011100528A2 (en) * | 2010-02-12 | 2011-08-18 | Emory University | Compositions and uses of lectins |
CN102813909A (zh) * | 2012-08-02 | 2012-12-12 | 青岛绿曼生物工程有限公司 | 防治家禽大肠杆菌病和慢性呼吸道疾病的复方盐酸多西环素组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
朱云芬等编译: "科技动态:阿比多尔可作为家禽呼吸道疾病的广谱药", 《中国家禽》 * |
李荣誉等: "防治鸡多病因呼吸道病药物的合理应用", 《中国家禽》 * |
邓翠芬等: "强力霉素对鸡大肠杆菌病的临床治疗效果", 《中国畜禽种业》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112315957A (zh) | 2021-02-05 |
CN106236758B (zh) | 2020-07-28 |
CN111870597A (zh) | 2020-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101584747A (zh) | 一种抗菌抗病毒兽用中药组合物 | |
WO2022139132A1 (ko) | 항미생물제 조성물과 제조방법 및 그 제품 | |
CN101780270A (zh) | 用于治疗禽呼吸道疾病的复方可溶性粉 | |
CN102895378B (zh) | 一种防治畜禽呼吸道疾病的药物复方制剂及其制备方法 | |
CN106236758A (zh) | 一种治疗鸡呼吸道细菌和病毒混合型感染的复方制剂及其制备方法 | |
CN103417571A (zh) | 用于治疗鸡支原体呼吸道感染的组合物及其制备方法 | |
CN102813910B (zh) | 一种用于防治禽类气囊炎的药物组合物及其制备方法 | |
CN101972325A (zh) | 用于治疗鸡球虫病的药物组合物及其制备方法 | |
CN102764252A (zh) | 一种盐酸沃尼妙林的用途 | |
CN102755342B (zh) | 复方对乙酰氨基酚注射液及其制备方法 | |
CN101780266A (zh) | 防治畜禽呼吸道疾病的复方制剂 | |
CN101780064B (zh) | 对羟基肉桂酸的用途 | |
CN102429993B (zh) | 一种治疗禽大肠杆菌病混合感染的复方口服液 | |
CN105943540B (zh) | 一种西米杜鹃醇的用途 | |
CN105168292B (zh) | 一种止咳平喘的兽用药物组合物及其制备方法 | |
CN113577167B (zh) | 祖师麻在制备治疗猪附红细胞体病药物中的应用 | |
CN103550705B (zh) | 治疗犬传染性支气管炎的组合物及其制备方法 | |
AU2020104238A4 (en) | A medicine for treating Newcastle disease, avian influenza and duck plague | |
CN101879179A (zh) | 复方氧氟沙星溶液及其制备方法 | |
CN106138392A (zh) | 一种防治畜禽呼吸道疾病的中药组合物及其制备方法 | |
CN105168444B (zh) | 一种用于防治畜禽呼吸道综合征药物 | |
KR102619907B1 (ko) | 가축설사 치료용 복합제 조성물 | |
CN101112377A (zh) | 治疗禽混合感染的药物组合物及其制备方法 | |
CN104586874A (zh) | 一种用于防治禽呼吸道感染的药物及其制备方法 | |
CN1840072A (zh) | 一种治疗禽呼吸道疾病的中兽药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A compound preparation for treating mixed infection of bacteria and virus in chicken respiratory tract and its preparation method Effective date of registration: 20210416 Granted publication date: 20200728 Pledgee: Weifang Jinma road sub branch of Bank of Weifang Co.,Ltd. Pledgor: SHANDONG JINGLY BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980002733 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220411 Granted publication date: 20200728 Pledgee: Weifang Jinma road sub branch of Bank of Weifang Co.,Ltd. Pledgor: SHANDONG JINGLY BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980002733 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a compound preparation for treating chicken respiratory tract bacterial and virus mixed infection and a preparation method thereof Effective date of registration: 20220414 Granted publication date: 20200728 Pledgee: Weifang Jinma road sub branch of Bank of Weifang Co.,Ltd. Pledgor: SHANDONG JINGLY BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022980004236 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230419 Granted publication date: 20200728 Pledgee: Weifang Jinma road sub branch of Bank of Weifang Co.,Ltd. Pledgor: SHANDONG JINGLY BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022980004236 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A compound preparation for treating mixed bacterial and viral infections in the respiratory tract of chickens and its preparation method Effective date of registration: 20230421 Granted publication date: 20200728 Pledgee: Weifang Jinma road sub branch of Bank of Weifang Co.,Ltd. Pledgor: SHANDONG JINGLY BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023980038641 |